CEO Q&A with Geremy Thomas at Sativa Investments PLC (NEX:SATI)

Sativa Investments PLC (NEX:SATI) Chief Executive Officer Geremy Thomas caught up with DirectorsTalk for an exclusive interview to discuss their cash flow position, the performance of their trading businesses and moving to become an operating company.

 

Q1: We saw today’s update surrounding the company’s next stages for growth, can you tell us what the current cash flow position is for Sativa Investments?

A1: We’re in a very strong position, we have over £3.6 million in the bank today.

 

Q2: What can you tell me about the trading businesses, how are they doing?

A2: We have two main trading businesses, one is our laboratory PhytoVista which is trading very satisfactory in fact we are close to breakeven after 5 months of trading so we’re very happy with that. The industry is using the services of our lab and that business is growing.

 

Q3: Today’s announcement seem to focus on a strategic move, shifting away from an investment vehicle to an operating company. What can you tell us about that along with Sativa Investment’s new company initiatives?

A3: Well, the second trading business we have is George Botanicals which is a manufacturer, wholesaler and retailer of CBD products and that really has seen significant growth since we started. That and the regulatory changes that we’ve seen, led by the government, has meant that our focus has moved away from investments in Canada which is where we started to a much closer focus at home and in Europe. So, we are very much switching from being an investment vehicle to an operating company looking to pursue a seed-to-consumer strategy.

So, that means that we want to grow medicinal cannabis, we want to extract what we need from it, we want to test it and then we want to brand it and sell it. We have identified a number of routes to market which we want to exploit.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Sativa Investments plc

    More articles like this

    DirectorsTalk

    CBD as a novel food: the UK’s stance post-Brexit

    The UK FSA’s announcements that it will consider novel food applications for CBD products stands in contrast to the position taken by the European Commission during the summer of 2020, who have currently ‘paused’ novel food

    DirectorsTalk

    What cannabinoids are found in CBD oils?

    CBD oils can be purely made from seeds or they can be a combination of cannabinoids, flavonoids, and terpenes. Every CBD oil is a little bit different, and you will want to make sure you read

    DirectorsTalk

    How the UK CBD industry is thriving in uncertain times

    This year covid-19 has hit hard with far-reaching economic implications for countries around the world. The United Kingdom is no exception as the economy has taken the brunt of the pandemic’s negative effects. However certain markets

    DirectorsTalk

    UK CBD market on a high

    Just when you thought the ‘hype’ around CBD adoption was a passing fad, UK’s nascent CBD market happens to be among the few industries maintaining an upward growth amidst the recent COVID-19 pandemic devastation in the

    DirectorsTalk

    How to integrate CBD oil into your diet

    The internet is awash with information and testimonies on the benefits of CBD oil and the potential that it has in alleviating a number of ailments. Whether or not some of these claims are true is

    DirectorsTalk

    Why should you choose CBD oil?

    Cannabidiol (CBD) is a non-psychoactive yet active chemical component among cannabinoids, a group of compounds found in marijuana plants otherwise known as Cannabis sativa. Conversely, Tetrahydrocannabinol (THC) is the principal psychoactive component that causes an intoxicating

    DirectorsTalk

    A guide to CBD

    What is CBD? CBD – It’s a relatively new product, but how can it benefit you? Most people haven’t even heard of it and yet it’s starting to appear in conversations around sports, food and beauty

    Sativa Group

    Is CBD oil legal in the UK?

    The legal status of CBD in the UK is reflected in many countries worldwide, with the main difference being the levels of THC allowed in the finished product. CBD has seen such a rapid rise to

    Sativa Group

    Sativa Group joins the ACI toxicology study

    As part of the Sativa Group PLC (AQUIS:SATI) ongoing commitment to continually deliver the highest level of regulatory compliance and substantiate ‘CBD you can trust’, the Company has become a member of the Association for the

    Sativa Group

    A comprehensive guide to CBD in the UK

    CBD is being added to products across the retail spectrum from food to make-up. According to claims by the Centre for Medical Cannabis, six million people in the UK have tried CBD, and this year the

    Sativa Group

    A new cannabis wellness era: A history of CBD

    Cannabis Sativa L. has been utilised for a large variety of ailments, industrial applications, and ceremonial uses for millennia. Evidence gathered from significant ancient sites has revealed that the plant was important, and even sacred, in

    Sativa Group

    How CBD can help level up your workout

    With gyms closed and group classes relegated to the online world, at-home workouts are the new normal. Feeling a bit lackluster after months of squats in your living room? Want a new solution so you can

    Sativa Group

    What is CBD? How does it work?

    What is CBD? It’s in everything from beauty products to lattes, but those three letters are thrown around so much that you’d be forgiven for not knowing what CBD is, exactly. More importantly, you might be wondering, is CBD safe?

    Sativa Group

    Sativa Group CSE conditionally approves Sativa Wellness Group

    Sativa Group plc (AQUIS:SATI) has announced that the Canadian Securities Exchange conditionally approved the Listing Application for Sativa Wellness Group Inc. on September 7, combining the operations of Sativa Group PLC and Stillcanna Inc. As previously